

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 9.50064952 |
| 2 | cardiac myofibril assembly (GO:0055003) | 9.28475359 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.07039717 |
| 4 | myofibril assembly (GO:0030239) | 8.03263949 |
| 5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.43009238 |
| 6 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 7.07489207 |
| 7 | * cardiac muscle contraction (GO:0060048) | 6.73661904 |
| 8 | cardiac muscle cell development (GO:0055013) | 6.73010789 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.71655962 |
| 10 | tricarboxylic acid cycle (GO:0006099) | 6.66488510 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.57219631 |
| 12 | regulation of actin filament-based movement (GO:1903115) | 6.44998638 |
| 13 | cardiac cell development (GO:0055006) | 6.32456547 |
| 14 | regulation of relaxation of muscle (GO:1901077) | 6.24430728 |
| 15 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.23371561 |
| 16 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.11436363 |
| 17 | adult heart development (GO:0007512) | 6.09145444 |
| 18 | ventricular cardiac muscle cell action potential (GO:0086005) | 6.07316624 |
| 19 | * actin-myosin filament sliding (GO:0033275) | 6.02440176 |
| 20 | * muscle filament sliding (GO:0030049) | 6.02440176 |
| 21 | actomyosin structure organization (GO:0031032) | 5.91608739 |
| 22 | cardiac muscle hypertrophy (GO:0003300) | 5.83576734 |
| 23 | * cardiac muscle tissue morphogenesis (GO:0055008) | 5.79684192 |
| 24 | plasma membrane repair (GO:0001778) | 5.76548042 |
| 25 | * ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.72815048 |
| 26 | regulation of sarcomere organization (GO:0060297) | 5.68532126 |
| 27 | detection of calcium ion (GO:0005513) | 5.68041684 |
| 28 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.64987344 |
| 29 | heart trabecula formation (GO:0060347) | 5.57948248 |
| 30 | striated muscle hypertrophy (GO:0014897) | 5.50405123 |
| 31 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.30063117 |
| 32 | regulation of the force of heart contraction (GO:0002026) | 5.18026137 |
| 33 | regulation of skeletal muscle contraction (GO:0014819) | 5.17702545 |
| 34 | regulation of striated muscle contraction (GO:0006942) | 5.13680175 |
| 35 | * muscle tissue morphogenesis (GO:0060415) | 5.12680014 |
| 36 | carnitine shuttle (GO:0006853) | 5.03881173 |
| 37 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.00415488 |
| 38 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.98256318 |
| 39 | * actin-mediated cell contraction (GO:0070252) | 4.96934718 |
| 40 | cell communication involved in cardiac conduction (GO:0086065) | 4.96027432 |
| 41 | * striated muscle contraction (GO:0006941) | 4.94938692 |
| 42 | regulation of cell communication by electrical coupling (GO:0010649) | 4.93970333 |
| 43 | cardiac chamber formation (GO:0003207) | 4.93569216 |
| 44 | muscle hypertrophy (GO:0014896) | 4.87768546 |
| 45 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.83619486 |
| 46 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.82310226 |
| 47 | regulation of membrane repolarization (GO:0060306) | 4.82052265 |
| 48 | cardiac ventricle formation (GO:0003211) | 4.76239034 |
| 49 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.62551052 |
| 50 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.50113047 |
| 51 | ATP synthesis coupled proton transport (GO:0015986) | 4.50113047 |
| 52 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.46672993 |
| 53 | regulation of cardiac muscle contraction (GO:0055117) | 4.46045110 |
| 54 | regulation of coenzyme metabolic process (GO:0051196) | 4.40301944 |
| 55 | regulation of cofactor metabolic process (GO:0051193) | 4.40301944 |
| 56 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.39905555 |
| 57 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.37687444 |
| 58 | fatty acid transmembrane transport (GO:1902001) | 4.36721620 |
| 59 | regulation of cardioblast differentiation (GO:0051890) | 4.32447189 |
| 60 | cell communication by electrical coupling (GO:0010644) | 4.30111102 |
| 61 | respiratory electron transport chain (GO:0022904) | 4.26592851 |
| 62 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.25630901 |
| 63 | positive regulation of action potential (GO:0045760) | 4.24600370 |
| 64 | regulation of heart rate (GO:0002027) | 4.23901433 |
| 65 | adrenergic receptor signaling pathway (GO:0071875) | 4.21787235 |
| 66 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.20836944 |
| 67 | relaxation of cardiac muscle (GO:0055119) | 4.16933927 |
| 68 | cardiac muscle adaptation (GO:0014887) | 4.15721486 |
| 69 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.15721486 |
| 70 | muscle hypertrophy in response to stress (GO:0003299) | 4.15721486 |
| 71 | cardiac muscle cell action potential (GO:0086001) | 4.15064834 |
| 72 | electron transport chain (GO:0022900) | 4.13836054 |
| 73 | oxidative phosphorylation (GO:0006119) | 4.12691574 |
| 74 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.12369133 |
| 75 | cardiac muscle tissue development (GO:0048738) | 4.09485908 |
| 76 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.08772468 |
| 77 | negative regulation of potassium ion transport (GO:0043267) | 4.07623003 |
| 78 | cellular response to epinephrine stimulus (GO:0071872) | 4.05741489 |
| 79 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.03959154 |
| 80 | ventricular cardiac muscle cell development (GO:0055015) | 4.03510673 |
| 81 | NADH metabolic process (GO:0006734) | 4.01160937 |
| 82 | atrial septum morphogenesis (GO:0060413) | 3.98662869 |
| 83 | response to epinephrine (GO:0071871) | 3.96332333 |
| 84 | regulation of heart contraction (GO:0008016) | 3.95414878 |
| 85 | atrioventricular valve morphogenesis (GO:0003181) | 3.95321965 |
| 86 | negative regulation of protein localization to cell surface (GO:2000009) | 3.95109983 |
| 87 | 2-oxoglutarate metabolic process (GO:0006103) | 3.93485942 |
| 88 | response to inactivity (GO:0014854) | 3.87318066 |
| 89 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.87029212 |
| 90 | response to caffeine (GO:0031000) | 3.83190830 |
| 91 | oxygen transport (GO:0015671) | 3.79973294 |
| 92 | cardiac conduction (GO:0061337) | 3.78341567 |
| 93 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.76262134 |
| 94 | regulation of sequestering of triglyceride (GO:0010889) | 3.72853464 |
| 95 | carnitine transmembrane transport (GO:1902603) | 3.72369416 |
| 96 | * actin filament-based movement (GO:0030048) | 3.71108081 |
| 97 | creatine metabolic process (GO:0006600) | 3.67674789 |
| 98 | positive regulation of heart rate (GO:0010460) | 3.67276446 |
| 99 | positive regulation of ATPase activity (GO:0032781) | 3.65859763 |
| 100 | positive regulation of ATP catabolic process (GO:1903291) | 3.65859763 |
| 101 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.65789224 |
| 102 | * muscle contraction (GO:0006936) | 3.64601240 |
| 103 | positive regulation of heart contraction (GO:0045823) | 3.64062079 |
| 104 | * regulation of muscle contraction (GO:0006937) | 3.62271775 |
| 105 | * regulation of ATPase activity (GO:0043462) | 3.61924033 |
| 106 | * regulation of ATP catabolic process (GO:1903289) | 3.61924033 |
| 107 | striated muscle cell development (GO:0055002) | 3.58936191 |
| 108 | regulation of sulfur metabolic process (GO:0042762) | 3.57998598 |
| 109 | striated muscle adaptation (GO:0014888) | 3.57486951 |
| 110 | positive regulation of cation channel activity (GO:2001259) | 3.56105758 |
| 111 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.55822672 |
| 112 | trabecula formation (GO:0060343) | 3.54927888 |
| 113 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.47420491 |
| 114 | * heart process (GO:0003015) | 3.43961965 |
| 115 | * heart contraction (GO:0060047) | 3.43961965 |
| 116 | regulation of cation channel activity (GO:2001257) | 3.38846633 |
| 117 | amino-acid betaine transport (GO:0015838) | 3.38565815 |
| 118 | carnitine transport (GO:0015879) | 3.38565815 |
| 119 | * muscle system process (GO:0003012) | 3.37446550 |
| 120 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.37339423 |
| 121 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.37339423 |
| 122 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.36027708 |
| 123 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.36027708 |
| 124 | potassium ion export (GO:0071435) | 3.35319290 |
| 125 | positive regulation of sodium ion transport (GO:0010765) | 3.34966166 |
| 126 | aspartate family amino acid catabolic process (GO:0009068) | 3.30165829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.11448737 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.37136524 |
| 3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.67189881 |
| 4 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.35548012 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.35548012 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.07648661 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.01439890 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.36701180 |
| 9 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.27766983 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.03068470 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.83815896 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.76217893 |
| 13 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.55078871 |
| 14 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.29289088 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.29279015 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.11938081 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.10255272 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.08961907 |
| 19 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.02693807 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.02674561 |
| 21 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.91673017 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85935618 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.76747094 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74156174 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70268593 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.61736078 |
| 27 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.59769174 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.59688514 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.54284252 |
| 30 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50652205 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47342398 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.43125706 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39161631 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.38905051 |
| 35 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.38177402 |
| 36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.33614403 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33391925 |
| 38 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33309297 |
| 39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.32594705 |
| 40 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.31893755 |
| 41 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.29756356 |
| 42 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28163063 |
| 43 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.26293504 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25729014 |
| 45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25084664 |
| 46 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.22405070 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21627630 |
| 48 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.21389817 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21220999 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20549666 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.19044587 |
| 52 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.17933487 |
| 53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.17933487 |
| 54 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17577721 |
| 55 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.17145808 |
| 56 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.15317666 |
| 57 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15303765 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14686057 |
| 59 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.13890842 |
| 60 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12543966 |
| 61 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.11265317 |
| 62 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.11208589 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10872701 |
| 64 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08610651 |
| 65 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.08304441 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07310381 |
| 67 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03755093 |
| 68 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02781422 |
| 69 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02170343 |
| 70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99460089 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97913464 |
| 72 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97564646 |
| 73 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97415788 |
| 74 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96236304 |
| 75 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.95824113 |
| 76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95003923 |
| 77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94975775 |
| 78 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94156874 |
| 79 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.94147329 |
| 80 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93928521 |
| 81 | P68_20966046_ChIP-Seq_HELA_Human | 0.93071697 |
| 82 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.92492280 |
| 83 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.91982707 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91119286 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90314343 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90313810 |
| 87 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89994735 |
| 88 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.89990276 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89926905 |
| 90 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89799172 |
| 91 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.89771825 |
| 92 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86211452 |
| 93 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85598016 |
| 94 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85511347 |
| 95 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.84913982 |
| 96 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.84642960 |
| 97 | TBL1_22424771_ChIP-Seq_293T_Human | 0.84466317 |
| 98 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84215406 |
| 99 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.82558132 |
| 100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81884116 |
| 101 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.80476190 |
| 102 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.80415157 |
| 103 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.79165822 |
| 104 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78803825 |
| 105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78512633 |
| 106 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77992938 |
| 107 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.77617281 |
| 108 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.77542024 |
| 109 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.77522973 |
| 110 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.77279010 |
| 111 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.77012802 |
| 112 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.76584172 |
| 113 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.76009690 |
| 114 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75812024 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75279432 |
| 116 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.74921925 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74884786 |
| 118 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.74805250 |
| 119 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.74031761 |
| 120 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.73889622 |
| 121 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.73687344 |
| 122 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.73304965 |
| 123 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.72937879 |
| 124 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.72551919 |
| 125 | CJUN_26792858_Chip-Seq_BT549_Human | 0.72468207 |
| 126 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.72160601 |
| 127 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.72088795 |
| 128 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.71356329 |
| 129 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71193678 |
| 130 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70989593 |
| 131 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.70865894 |
| 132 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.70706017 |
| 133 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.70699335 |
| 134 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70466238 |
| 135 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.69656732 |
| 136 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69655618 |
| 137 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.69366648 |
| 138 | * GF1_26923725_Chip-Seq_HPCs_Mouse | 0.69076718 |
| 139 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.67866380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 7.21603981 |
| 2 | MP0004084_abnormal_cardiac_muscle | 6.19446906 |
| 3 | MP0003646_muscle_fatigue | 5.57423588 |
| 4 | MP0004215_abnormal_myocardial_fiber | 5.07096731 |
| 5 | MP0000751_myopathy | 5.00800504 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.33736477 |
| 7 | MP0005330_cardiomyopathy | 4.08149883 |
| 8 | MP0000749_muscle_degeneration | 3.61144748 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.34869372 |
| 10 | MP0008775_abnormal_heart_ventricle | 3.16994009 |
| 11 | MP0003137_abnormal_impulse_conducting | 3.12194700 |
| 12 | * MP0004087_abnormal_muscle_fiber | 2.94597108 |
| 13 | * MP0005385_cardiovascular_system_phenoty | 2.70958882 |
| 14 | * MP0001544_abnormal_cardiovascular_syste | 2.70958882 |
| 15 | * MP0010630_abnormal_cardiac_muscle | 2.66100988 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.64678424 |
| 17 | MP0000750_abnormal_muscle_regeneration | 2.61663497 |
| 18 | MP0004484_altered_response_of | 2.56881074 |
| 19 | MP0003828_pulmonary_edema | 2.48416601 |
| 20 | MP0004130_abnormal_muscle_cell | 2.37825812 |
| 21 | MP0002106_abnormal_muscle_physiology | 2.32532549 |
| 22 | MP0004085_abnormal_heartbeat | 2.32396443 |
| 23 | * MP0006138_congestive_heart_failure | 2.26722867 |
| 24 | MP0002269_muscular_atrophy | 2.14688019 |
| 25 | MP0003221_abnormal_cardiomyocyte_apopto | 2.05393064 |
| 26 | MP0004510_myositis | 2.04606752 |
| 27 | MP0005369_muscle_phenotype | 1.86682668 |
| 28 | MP0002127_abnormal_cardiovascular_syste | 1.75991737 |
| 29 | MP0000759_abnormal_skeletal_muscle | 1.74585407 |
| 30 | MP0006036_abnormal_mitochondrial_physio | 1.70834000 |
| 31 | MP0000747_muscle_weakness | 1.67366007 |
| 32 | MP0004145_abnormal_muscle_electrophysio | 1.64786764 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.60633081 |
| 34 | MP0004233_abnormal_muscle_weight | 1.56545688 |
| 35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.42165414 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.39436008 |
| 37 | MP0002332_abnormal_exercise_endurance | 1.32344797 |
| 38 | MP0005670_abnormal_white_adipose | 1.28823429 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.26953609 |
| 40 | MP0000343_altered_response_to | 1.25896063 |
| 41 | MP0003279_aneurysm | 1.23373273 |
| 42 | * MP0000266_abnormal_heart_morphology | 1.18257829 |
| 43 | MP0005165_increased_susceptibility_to | 1.16733477 |
| 44 | MP0002234_abnormal_pharynx_morphology | 1.14470609 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 0.99619431 |
| 46 | MP0005375_adipose_tissue_phenotype | 0.91251446 |
| 47 | MP0001661_extended_life_span | 0.90066187 |
| 48 | MP0004185_abnormal_adipocyte_glucose | 0.88815228 |
| 49 | MP0002128_abnormal_blood_circulation | 0.86535510 |
| 50 | MP0000230_abnormal_systemic_arterial | 0.86089652 |
| 51 | MP0008004_abnormal_stomach_pH | 0.85964889 |
| 52 | MP0005623_abnormal_meninges_morphology | 0.85045235 |
| 53 | MP0003566_abnormal_cell_adhesion | 0.82500997 |
| 54 | MP0005503_abnormal_tendon_morphology | 0.81071767 |
| 55 | MP0005266_abnormal_metabolism | 0.79057611 |
| 56 | MP0001879_abnormal_lymphatic_vessel | 0.71590869 |
| 57 | MP0002909_abnormal_adrenal_gland | 0.68821768 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 0.68655844 |
| 59 | MP0002108_abnormal_muscle_morphology | 0.68492678 |
| 60 | MP0000767_abnormal_smooth_muscle | 0.67976649 |
| 61 | MP0005451_abnormal_body_composition | 0.66112185 |
| 62 | MP0005409_darkened_coat_color | 0.62480594 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 0.62107707 |
| 64 | MP0004272_abnormal_basement_membrane | 0.60369535 |
| 65 | MP0004043_abnormal_pH_regulation | 0.57550458 |
| 66 | MP0005187_abnormal_penis_morphology | 0.54028862 |
| 67 | MP0001984_abnormal_olfaction | 0.52060415 |
| 68 | MP0008438_abnormal_cutaneous_collagen | 0.51739525 |
| 69 | MP0002925_abnormal_cardiovascular_devel | 0.51141329 |
| 70 | MP0000003_abnormal_adipose_tissue | 0.50614200 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 0.49073869 |
| 72 | MP0003984_embryonic_growth_retardation | 0.48067114 |
| 73 | MP0004147_increased_porphyrin_level | 0.47545497 |
| 74 | MP0002088_abnormal_embryonic_growth/wei | 0.46677398 |
| 75 | MP0002638_abnormal_pupillary_reflex | 0.46344977 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.42899836 |
| 77 | MP0009384_cardiac_valve_regurgitation | 0.40707059 |
| 78 | MP0001614_abnormal_blood_vessel | 0.39895646 |
| 79 | MP0001784_abnormal_fluid_regulation | 0.39286190 |
| 80 | MP0000013_abnormal_adipose_tissue | 0.38817161 |
| 81 | MP0002971_abnormal_brown_adipose | 0.38322016 |
| 82 | MP0000733_abnormal_muscle_development | 0.37334914 |
| 83 | MP0003136_yellow_coat_color | 0.35536521 |
| 84 | MP0005275_abnormal_skin_tensile | 0.34789457 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.33300950 |
| 86 | MP0005535_abnormal_body_temperature | 0.31909602 |
| 87 | MP0005595_abnormal_vascular_smooth | 0.31779656 |
| 88 | MP0002090_abnormal_vision | 0.31097559 |
| 89 | MP0005386_behavior/neurological_phenoty | 0.30502247 |
| 90 | MP0004924_abnormal_behavior | 0.30502247 |
| 91 | MP0003948_abnormal_gas_homeostasis | 0.29924371 |
| 92 | MP0003045_fibrosis | 0.29431108 |
| 93 | MP0009840_abnormal_foam_cell | 0.29277964 |
| 94 | MP0003941_abnormal_skin_development | 0.28378227 |
| 95 | MP0001727_abnormal_embryo_implantation | 0.27214867 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 0.26536216 |
| 97 | MP0005380_embryogenesis_phenotype | 0.26332265 |
| 98 | MP0001672_abnormal_embryogenesis/_devel | 0.26332265 |
| 99 | MP0001958_emphysema | 0.26011003 |
| 100 | MP0002822_catalepsy | 0.25356325 |
| 101 | MP0000249_abnormal_blood_vessel | 0.24571557 |
| 102 | MP0003195_calcinosis | 0.24394088 |
| 103 | MP0002133_abnormal_respiratory_system | 0.24064502 |
| 104 | MP0005388_respiratory_system_phenotype | 0.24064502 |
| 105 | MP0002118_abnormal_lipid_homeostasis | 0.22894658 |
| 106 | MP0006072_abnormal_retinal_apoptosis | 0.22225781 |
| 107 | MP0005334_abnormal_fat_pad | 0.22153179 |
| 108 | MP0005083_abnormal_biliary_tract | 0.20612411 |
| 109 | MP0005332_abnormal_amino_acid | 0.20089121 |
| 110 | MP0002877_abnormal_melanocyte_morpholog | 0.19727016 |
| 111 | MP0005376_homeostasis/metabolism_phenot | 0.19400530 |
| 112 | MP0001299_abnormal_eye_distance/ | 0.19042538 |
| 113 | MP0009763_increased_sensitivity_to | 0.18643613 |
| 114 | MP0009115_abnormal_fat_cell | 0.18371171 |
| 115 | MP0009780_abnormal_chondrocyte_physiolo | 0.18114078 |
| 116 | MP0002254_reproductive_system_inflammat | 0.17971615 |
| 117 | MP0000579_abnormal_nail_morphology | 0.16444901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.65683405 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.58431040 |
| 3 | * Atrial fibrillation (HP:0005110) | 6.37145026 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.23614220 |
| 5 | * Primary atrial arrhythmia (HP:0001692) | 5.94770496 |
| 6 | * Supraventricular tachycardia (HP:0004755) | 5.75064530 |
| 7 | * Supraventricular arrhythmia (HP:0005115) | 5.63659504 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.55185373 |
| 9 | * Lipoatrophy (HP:0100578) | 5.52336680 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 5.46993078 |
| 11 | Muscle fiber splitting (HP:0003555) | 5.40440879 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 5.33293321 |
| 13 | Syncope (HP:0001279) | 5.30033214 |
| 14 | Exercise-induced myalgia (HP:0003738) | 5.23271107 |
| 15 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.22088419 |
| 16 | Subaortic stenosis (HP:0001682) | 5.22088419 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 5.20551920 |
| 18 | Bundle branch block (HP:0011710) | 4.96466140 |
| 19 | Palpitations (HP:0001962) | 4.84253308 |
| 20 | Hyporeflexia of lower limbs (HP:0002600) | 4.77688039 |
| 21 | Prolonged QT interval (HP:0001657) | 4.72635306 |
| 22 | Myoglobinuria (HP:0002913) | 4.61116850 |
| 23 | * Dilated cardiomyopathy (HP:0001644) | 4.54345873 |
| 24 | Ventricular arrhythmia (HP:0004308) | 4.32396654 |
| 25 | Heart block (HP:0012722) | 4.16265022 |
| 26 | Asymmetric septal hypertrophy (HP:0001670) | 4.13310005 |
| 27 | Ventricular fibrillation (HP:0001663) | 4.09053813 |
| 28 | Atrioventricular block (HP:0001678) | 4.08731597 |
| 29 | EMG: myopathic abnormalities (HP:0003458) | 3.92497240 |
| 30 | Abnormal atrioventricular conduction (HP:0005150) | 3.92391716 |
| 31 | Increased connective tissue (HP:0009025) | 3.66178053 |
| 32 | Rhabdomyolysis (HP:0003201) | 3.49324735 |
| 33 | Abnormal EKG (HP:0003115) | 3.41011771 |
| 34 | Type 1 muscle fiber predominance (HP:0003803) | 3.29152221 |
| 35 | Hepatic necrosis (HP:0002605) | 3.23643699 |
| 36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.23356391 |
| 37 | Acute necrotizing encephalopathy (HP:0006965) | 3.22153177 |
| 38 | Left ventricular hypertrophy (HP:0001712) | 3.19517062 |
| 39 | Myotonia (HP:0002486) | 3.15952654 |
| 40 | Difficulty running (HP:0009046) | 3.04106830 |
| 41 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.94933245 |
| 42 | Ketoacidosis (HP:0001993) | 2.86577913 |
| 43 | Hepatocellular necrosis (HP:0001404) | 2.82213796 |
| 44 | Hypoglycemic coma (HP:0001325) | 2.77140578 |
| 45 | Acute encephalopathy (HP:0006846) | 2.76563500 |
| 46 | Rimmed vacuoles (HP:0003805) | 2.76119004 |
| 47 | * Palmoplantar keratoderma (HP:0000982) | 2.72962086 |
| 48 | Progressive macrocephaly (HP:0004481) | 2.66802602 |
| 49 | Abnormality of the tricuspid valve (HP:0001702) | 2.66715380 |
| 50 | Difficulty climbing stairs (HP:0003551) | 2.65965736 |
| 51 | Mitochondrial inheritance (HP:0001427) | 2.63238853 |
| 52 | Cerebral edema (HP:0002181) | 2.55641352 |
| 53 | Ragged-red muscle fibers (HP:0003200) | 2.55308053 |
| 54 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.54982111 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.54357279 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.50187264 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50187264 |
| 58 | Hypoplastic heart (HP:0001961) | 2.49702886 |
| 59 | Testicular atrophy (HP:0000029) | 2.48223151 |
| 60 | Conjunctival hamartoma (HP:0100780) | 2.48048772 |
| 61 | Increased CSF lactate (HP:0002490) | 2.47985470 |
| 62 | Increased muscle lipid content (HP:0009058) | 2.47356989 |
| 63 | Increased serum pyruvate (HP:0003542) | 2.40106068 |
| 64 | Limb-girdle muscle atrophy (HP:0003797) | 2.34908168 |
| 65 | Generalized muscle weakness (HP:0003324) | 2.29622414 |
| 66 | Sudden cardiac death (HP:0001645) | 2.29199622 |
| 67 | Abnormality of glycolysis (HP:0004366) | 2.25770873 |
| 68 | Pheochromocytoma (HP:0002666) | 2.23153564 |
| 69 | Respiratory failure (HP:0002878) | 2.22625077 |
| 70 | Areflexia of lower limbs (HP:0002522) | 2.22020928 |
| 71 | Lactic acidosis (HP:0003128) | 2.21175818 |
| 72 | Exercise intolerance (HP:0003546) | 2.20650281 |
| 73 | Increased variability in muscle fiber diameter (HP:0003557) | 2.18463915 |
| 74 | Increased intramyocellular lipid droplets (HP:0012240) | 2.14365599 |
| 75 | Abnormality of the foot musculature (HP:0001436) | 2.10239597 |
| 76 | Ketosis (HP:0001946) | 2.10208248 |
| 77 | Bradycardia (HP:0001662) | 2.09683656 |
| 78 | Scapular winging (HP:0003691) | 2.09163468 |
| 79 | Double outlet right ventricle (HP:0001719) | 2.08851906 |
| 80 | Congenital malformation of the right heart (HP:0011723) | 2.08851906 |
| 81 | Dysmetric saccades (HP:0000641) | 2.06373111 |
| 82 | Neoplasm of the adrenal gland (HP:0100631) | 2.03713139 |
| 83 | Hamartoma of the eye (HP:0010568) | 2.03346020 |
| 84 | Neck muscle weakness (HP:0000467) | 2.02669552 |
| 85 | Muscle stiffness (HP:0003552) | 2.01462011 |
| 86 | Neuroendocrine neoplasm (HP:0100634) | 2.00256557 |
| 87 | * Congestive heart failure (HP:0001635) | 1.98423219 |
| 88 | Large for gestational age (HP:0001520) | 1.97155669 |
| 89 | Esophageal neoplasm (HP:0100751) | 1.97029808 |
| 90 | Neoplasm of head and neck (HP:0012288) | 1.97029808 |
| 91 | Progressive external ophthalmoplegia (HP:0000590) | 1.96302267 |
| 92 | Foot dorsiflexor weakness (HP:0009027) | 1.94265106 |
| 93 | Abnormality of alanine metabolism (HP:0010916) | 1.93801569 |
| 94 | Hyperalaninemia (HP:0003348) | 1.93801569 |
| 95 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.93801569 |
| 96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93359384 |
| 97 | Steppage gait (HP:0003376) | 1.92438651 |
| 98 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.88258617 |
| 99 | Hypoplastic left heart (HP:0004383) | 1.87564284 |
| 100 | Abnormality of the endocardium (HP:0004306) | 1.87016419 |
| 101 | Distal lower limb amyotrophy (HP:0008944) | 1.84122310 |
| 102 | Lymphangioma (HP:0100764) | 1.83496823 |
| 103 | Generalized aminoaciduria (HP:0002909) | 1.81965555 |
| 104 | Proximal amyotrophy (HP:0007126) | 1.80626050 |
| 105 | Pulmonary artery stenosis (HP:0004415) | 1.80431924 |
| 106 | Resting tremor (HP:0002322) | 1.80297134 |
| 107 | Hypoplastic ischia (HP:0003175) | 1.79880513 |
| 108 | Progressive muscle weakness (HP:0003323) | 1.79688443 |
| 109 | Tinnitus (HP:0000360) | 1.77292155 |
| 110 | Central scotoma (HP:0000603) | 1.76889007 |
| 111 | Lower limb amyotrophy (HP:0007210) | 1.76701672 |
| 112 | EMG: neuropathic changes (HP:0003445) | 1.75832167 |
| 113 | Bulbar palsy (HP:0001283) | 1.74582964 |
| 114 | Lipid accumulation in hepatocytes (HP:0006561) | 1.74478251 |
| 115 | Muscular dystrophy (HP:0003560) | 1.74014594 |
| 116 | Broad metatarsal (HP:0001783) | 1.73299406 |
| 117 | Athetosis (HP:0002305) | 1.73058906 |
| 118 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.73007116 |
| 119 | Skin nodule (HP:0200036) | 1.71572402 |
| 120 | Anomalous pulmonary venous return (HP:0010772) | 1.71069819 |
| 121 | Transposition of the great arteries (HP:0001669) | 1.69170481 |
| 122 | Abnormal connection of the cardiac segments (HP:0011545) | 1.69170481 |
| 123 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.69170481 |
| 124 | Periauricular skin pits (HP:0100277) | 1.66800599 |
| 125 | Preauricular pit (HP:0004467) | 1.66800599 |
| 126 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.63915882 |
| 127 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.59379847 |
| 128 | Skin pits (HP:0100276) | 1.54318545 |
| 129 | Late onset (HP:0003584) | 1.51960544 |
| 130 | Limb hypertonia (HP:0002509) | 1.48528631 |
| 131 | Gowers sign (HP:0003391) | 1.48187326 |
| 132 | Frequent falls (HP:0002359) | 1.45587173 |
| 133 | Abnormality of the pulmonary veins (HP:0011718) | 1.45225714 |
| 134 | Muscle fiber inclusion bodies (HP:0100299) | 1.39812464 |
| 135 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.38435264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.11818619 |
| 2 | LMTK2 | 4.62325919 |
| 3 | PHKG2 | 3.99533867 |
| 4 | PHKG1 | 3.99533867 |
| 5 | PDK3 | 3.68177560 |
| 6 | PDK4 | 3.68177560 |
| 7 | OBSCN | 3.56217545 |
| 8 | PKN2 | 3.51992242 |
| 9 | DMPK | 3.29885419 |
| 10 | TRIB3 | 2.85869620 |
| 11 | BCKDK | 2.72218770 |
| 12 | PIK3CA | 2.60367510 |
| 13 | TIE1 | 2.46391644 |
| 14 | MUSK | 2.42449145 |
| 15 | STK24 | 2.36844451 |
| 16 | NEK1 | 2.27923252 |
| 17 | MAP3K6 | 2.22740977 |
| 18 | PDK2 | 2.21903283 |
| 19 | PINK1 | 1.98191961 |
| 20 | MARK1 | 1.87546827 |
| 21 | GRK7 | 1.83836875 |
| 22 | CAMK2D | 1.52570552 |
| 23 | LIMK1 | 1.48885587 |
| 24 | ILK | 1.40637446 |
| 25 | CDC42BPA | 1.36130265 |
| 26 | WNK4 | 1.28921682 |
| 27 | ROCK1 | 1.18469580 |
| 28 | * PRKD1 | 1.14967471 |
| 29 | STK38L | 1.10895323 |
| 30 | ZAK | 1.06643273 |
| 31 | FLT3 | 1.06307985 |
| 32 | DAPK3 | 1.05991328 |
| 33 | MAP3K5 | 1.01216325 |
| 34 | RIPK1 | 1.00014636 |
| 35 | MAPK12 | 0.96548901 |
| 36 | TRPM7 | 0.95582331 |
| 37 | MAPKAPK3 | 0.94090453 |
| 38 | CAMK4 | 0.93909696 |
| 39 | PKN1 | 0.92772007 |
| 40 | INSRR | 0.92381933 |
| 41 | MAP3K7 | 0.91871442 |
| 42 | PDGFRA | 0.88683272 |
| 43 | PRKAA2 | 0.86377918 |
| 44 | ITK | 0.83132077 |
| 45 | KDR | 0.82579995 |
| 46 | MAPK4 | 0.81512052 |
| 47 | CAMK2B | 0.78499020 |
| 48 | STK38 | 0.78441333 |
| 49 | WNK1 | 0.75267360 |
| 50 | CAMK2A | 0.72432949 |
| 51 | TGFBR2 | 0.71894520 |
| 52 | CAMK1 | 0.67788216 |
| 53 | PTK2B | 0.66349059 |
| 54 | EPHB1 | 0.64215837 |
| 55 | MAP3K3 | 0.61459061 |
| 56 | MAP2K3 | 0.60540918 |
| 57 | * PRKAA1 | 0.57405751 |
| 58 | STK39 | 0.55332074 |
| 59 | BLK | 0.55135988 |
| 60 | ICK | 0.52576273 |
| 61 | MAP2K1 | 0.49160263 |
| 62 | NME2 | 0.46689514 |
| 63 | PRKD3 | 0.44382741 |
| 64 | PDPK1 | 0.43663444 |
| 65 | * PRKACA | 0.42775255 |
| 66 | * PRKACB | 0.42434003 |
| 67 | * MYLK | 0.40968163 |
| 68 | PRKCH | 0.39995540 |
| 69 | PTK6 | 0.39357890 |
| 70 | * PRKACG | 0.38474202 |
| 71 | NEK9 | 0.36872966 |
| 72 | PDK1 | 0.36822885 |
| 73 | TESK1 | 0.35852426 |
| 74 | NLK | 0.34918807 |
| 75 | CAMK2G | 0.34823558 |
| 76 | PIK3CG | 0.34395491 |
| 77 | PRPF4B | 0.33987386 |
| 78 | PRKG2 | 0.33850409 |
| 79 | SIK1 | 0.33187175 |
| 80 | AKT2 | 0.32207530 |
| 81 | EPHB2 | 0.31752246 |
| 82 | STK11 | 0.29325591 |
| 83 | FER | 0.28062816 |
| 84 | SGK2 | 0.28050395 |
| 85 | JAK1 | 0.27407746 |
| 86 | MAPK10 | 0.27325819 |
| 87 | RET | 0.27032600 |
| 88 | MTOR | 0.26852795 |
| 89 | LATS2 | 0.25801903 |
| 90 | AKT1 | 0.24735334 |
| 91 | SGK3 | 0.24475800 |
| 92 | MAPK9 | 0.23858692 |
| 93 | MARK2 | 0.23492581 |
| 94 | * ROCK2 | 0.23256131 |
| 95 | AKT3 | 0.22942075 |
| 96 | LRRK2 | 0.22467343 |
| 97 | ZAP70 | 0.21636796 |
| 98 | RPS6KA2 | 0.21143438 |
| 99 | FGFR4 | 0.21048971 |
| 100 | * PRKCE | 0.21014940 |
| 101 | LATS1 | 0.21013637 |
| 102 | PRKG1 | 0.20941490 |
| 103 | SGK223 | 0.20670341 |
| 104 | SGK494 | 0.20670341 |
| 105 | KSR2 | 0.19193260 |
| 106 | TGFBR1 | 0.18909695 |
| 107 | PDGFRB | 0.18026830 |
| 108 | PAK2 | 0.17956991 |
| 109 | * RPS6KA1 | 0.17690082 |
| 110 | CDK5 | 0.17525287 |
| 111 | SGK1 | 0.16104696 |
| 112 | MAPK7 | 0.15599878 |
| 113 | MAPK3 | 0.15466312 |
| 114 | EPHA3 | 0.14970818 |
| 115 | MAPKAPK2 | 0.14588491 |
| 116 | MAP3K10 | 0.14488454 |
| 117 | PLK4 | 0.14351551 |
| 118 | PRKCQ | 0.13620731 |
| 119 | MAP3K1 | 0.12430687 |
| 120 | MAPK8 | 0.12055498 |
| 121 | ADRBK1 | 0.11878196 |
| 122 | * RPS6KA3 | 0.11606736 |
| 123 | JAK2 | 0.11433980 |
| 124 | RPS6KA5 | 0.11085421 |
| 125 | PAK6 | 0.09900660 |
| 126 | PRKD2 | 0.09885866 |
| 127 | UHMK1 | 0.09116866 |
| 128 | MAPK11 | 0.08798624 |
| 129 | CAMK1D | 0.07904699 |
| 130 | MARK3 | 0.06724722 |
| 131 | TAOK1 | 0.06584252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.00611865 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.37478571 |
| 3 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.26804362 |
| 4 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.62653770 |
| 5 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.45374059 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.45257296 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 3.44365704 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.36553813 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.29665166 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.98135595 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.51430938 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.50921612 |
| 13 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.35312022 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33630514 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.30911208 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.25583900 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 2.17987917 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.82179930 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.82090566 |
| 20 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62952700 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.51905382 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.44845629 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37754742 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.21808551 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.17997082 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12867921 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10831590 |
| 28 | Insulin resistance_Homo sapiens_hsa04931 | 0.98566092 |
| 29 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98509125 |
| 30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91451167 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90821156 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88577506 |
| 33 | Lysine degradation_Homo sapiens_hsa00310 | 0.86527405 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86341867 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81856319 |
| 36 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76527583 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75055296 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74960459 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72469742 |
| 40 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69109340 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 0.69082621 |
| 42 | Focal adhesion_Homo sapiens_hsa04510 | 0.68186692 |
| 43 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68128345 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66537526 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63925895 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61752388 |
| 47 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58712460 |
| 48 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56708845 |
| 49 | GABAergic synapse_Homo sapiens_hsa04727 | 0.55898196 |
| 50 | Prion diseases_Homo sapiens_hsa05020 | 0.54557563 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54286218 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53960307 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 0.52078707 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49005726 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48043690 |
| 56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47511495 |
| 57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47495996 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 0.47341455 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46602835 |
| 60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46550968 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45873120 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43741454 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.43730695 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43018807 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 0.39230531 |
| 66 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37174183 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37058591 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34152558 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.33375986 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.32837449 |
| 71 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.32794440 |
| 72 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32625047 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32312200 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.31876015 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31652556 |
| 76 | Insulin secretion_Homo sapiens_hsa04911 | 0.30392642 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.29439519 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26813652 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.26798642 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.26112211 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23539150 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23492631 |
| 83 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.21922135 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.21799085 |
| 85 | Circadian entrainment_Homo sapiens_hsa04713 | 0.20705046 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19646178 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.19167308 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.18149357 |
| 89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.17907750 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.17816411 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.17381734 |
| 92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.17029916 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16713222 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16567367 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.15986608 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.15521639 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15446429 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.15202716 |
| 99 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.14807203 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.14504320 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.12356896 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11759970 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.11687928 |
| 104 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.11138812 |
| 105 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.10607306 |
| 106 | Gap junction_Homo sapiens_hsa04540 | 0.10330924 |
| 107 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.10285489 |
| 108 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.09411910 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.07485408 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.07397490 |
| 111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.07172513 |
| 112 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.06980845 |
| 113 | Taste transduction_Homo sapiens_hsa04742 | 0.06294416 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.06090182 |
| 115 | Bile secretion_Homo sapiens_hsa04976 | 0.05625560 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.05399349 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.05003654 |
| 118 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.04103201 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.03651339 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.03364934 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.02946880 |
| 122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.02736198 |
| 123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.00250843 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | -0.0414261 |
| 125 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0112099 |

